Regions Financial Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $446K | Buy |
2,359
+11
| +0.5% | +$1.92K | ﹤0.01% | 640 |
|
|
2025
Q4 | $399K | Buy |
2,348
+344
| +17% | +$52.7K | ﹤0.01% | 663 |
|
|
2025
Q3 | $264K | Sell |
2,004
-28
| -1% | -$3.36K | ﹤0.01% | 752 |
|
|
2025
Q2 | $216K | Sell |
2,032
-132
| -6% | -$14.3K | ﹤0.01% | 797 |
|
|
2025
Q1 | $269K | Buy |
2,164
+86
| +4% | +$11.2K | ﹤0.01% | 718 |
|
|
2024
Q4 | $256K | Buy |
2,078
+11
| +0.5% | +$1.3K | ﹤0.01% | 738 |
|
|
2024
Q3 | $230K | Sell |
2,067
-45
| -2% | -$4.93K | ﹤0.01% | 775 |
|
|
2024
Q2 | $225K | Sell |
2,112
-64
| -3% | -$7.04K | ﹤0.01% | 759 |
|
|
2024
Q1 | $262K | Sell |
2,176
-85
| -4% | -$10.4K | ﹤0.01% | 735 |
|
|
2023
Q4 | $278K | Sell |
2,261
-129
| -5% | -$16.1K | ﹤0.01% | 721 |
|
|
2023
Q3 | $309K | Buy |
2,390
+64
| +3% | +$8.53K | ﹤0.01% | 674 |
|
|
2023
Q2 | $288K | Hold |
2,326
| – | – | ﹤0.01% | 700 |
|
|
2023
Q1 | $340K | Sell |
2,326
-118
| -5% | -$17.5K | ﹤0.01% | 672 |
|
|
2022
Q4 | $389K | Sell |
2,444
-29
| -1% | -$4.25K | ﹤0.01% | 639 |
|
|
2022
Q3 | $329K | Sell |
2,473
-793
| -24% | -$121K | ﹤0.01% | 668 |
|
|
2022
Q2 | $509K | Buy |
3,266
+118
| +4% | +$18.2K | ﹤0.01% | 587 |
|
|
2022
Q1 | $490K | Buy |
3,148
+38
| +1% | +$5.51K | ﹤0.01% | 632 |
|
|
2021
Q4 | $396K | Buy |
3,110
+521
| +20% | +$68.5K | ﹤0.01% | 698 |
|
|
2021
Q3 | $337K | Sell |
2,589
-20
| -0.8% | -$3.02K | ﹤0.01% | 724 |
|
|
2021
Q2 | $464K | Sell |
2,609
-441
| -14% | -$76.4K | ﹤0.01% | 632 |
|
|
2021
Q1 | $502K | Buy |
3,050
+407
| +15% | +$67K | ﹤0.01% | 577 |
|
|
2020
Q4 | $437K | Sell |
2,643
-35
| -1% | -$5.21K | ﹤0.01% | 589 |
|
|
2020
Q3 | $382K | Sell |
2,678
-11
| -0.4% | -$1.36K | ﹤0.01% | 583 |
|
|
2020
Q2 | $297K | Buy |
2,689
+482
| +22% | +$53.3K | ﹤0.01% | 629 |
|
|
2020
Q1 | $220K | Buy |
+2,207
| New | +$285K | ﹤0.01% | 689 |
|
|
2019
Q2 | – | Sell |
-736
| Closed | -$105K | – | 1273 |
|
|
2019
Q1 | $105K | Buy |
736
+34
| +5% | +$4.43K | ﹤0.01% | 965 |
|
|
2018
Q4 | $87K | Buy |
702
+544
| +344% | +$80.7K | ﹤0.01% | 1001 |
|
|
2018
Q3 | $27K | Sell |
158
-5
| -3% | -$860 | ﹤0.01% | 1373 |
|
|
2018
Q2 | $28K | Buy |
163
+78
| +92% | +$12.8K | ﹤0.01% | 1364 |
|
|
2018
Q1 | $13K | Hold |
85
| – | – | ﹤0.01% | 1577 |
|
|
2017
Q4 | $11K | Buy |
+85
| New | +$11.8K | ﹤0.01% | 1650 |
|
|
2017
Q1 | – | Sell |
-4,994
| Closed | -$545K | – | 889 |
|
|
2016
Q4 | $545K | Sell |
4,994
-121
| -2% | -$13.5K | 0.01% | 635 |
|
|
2016
Q3 | $622K | Sell |
5,115
-380
| -7% | -$51.2K | 0.01% | 604 |
|
|
2016
Q2 | $777K | Sell |
5,495
-398
| -7% | -$58.7K | 0.01% | 544 |
|
|
2016
Q1 | $769K | Sell |
5,893
-1,866
| -24% | -$232K | 0.01% | 551 |
|
|
2015
Q4 | $1.09M | Buy |
7,759
+613
| +9% | +$84.9K | 0.01% | 482 |
|
|
2015
Q3 | $949K | Buy |
7,146
+428
| +6% | +$73.7K | 0.01% | 501 |
|
|
2015
Q2 | $1.18M | Sell |
6,718
-320
| -5% | -$57.5K | 0.02% | 467 |
|
|
2015
Q1 | $1.22M | Sell |
7,038
-159
| -2% | -$27.3K | 0.02% | 461 |
|
|
2014
Q4 | $1.18M | Sell |
7,197
-195
| -3% | -$32.4K | 0.02% | 475 |
|
|
2014
Q3 | $1.19M | Buy |
7,392
+2,504
| +51% | +$385K | 0.01% | 539 |
|
|
2014
Q2 | $719K | Buy |
+4,888
| New | +$678K | 0.01% | 695 |
|
|
2014
Q1 | – | Sell |
-2,025
| Closed | -$256K | – | 1119 |
|
|
2013
Q4 | $256K | Buy |
+2,025
| New | +$210K | ﹤0.01% | 973 |
|
Other funds holding JAZZ
VPM
VCM
EC
Regions Financial Corp's JAZZ Position: Q1 2026 in Review
Regions Financial Corp increased its Jazz Pharmaceuticals (JAZZ) stake by 0.47% in Q1 2026, buying an estimated $1.92K and bringing the position to 2,359 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #640.
Regions Financial Corp first reported a position in JAZZ in Q4 2013 and has held it in 43 quarters since. The position peaked at $1.22M in Q1 2015. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Regions Financial Corp held 2,359 shares of Jazz Pharmaceuticals worth $446K as of Q1 2026.
- Regions Financial Corp bought 11 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.92K.
- Jazz Pharmaceuticals made up ﹤0.01% of Regions Financial Corp's portfolio in Q1 2026, its #640 holding.
- Regions Financial Corp first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 43 quarters since.
- Regions Financial Corp's Jazz Pharmaceuticals position peaked at $1.22M in Q1 2015.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Regions Financial Corp's 13F filing for Q1 2026, filed 5 May 2026.